Author breaks JAMA journal embargo on his own study with New York Times cancer screening op-ed

Gil Welch, via Dartmouth

Gil Welch, who has scrutinized cancer screening in a number of venues, has two-thirds of a publishing hat trick this week: An op-ed in the New York Times, and an article in JAMA Internal Medicine.

Trouble is, the op-ed broke the embargo on the JAMA Internal Medicine paper.

From the JAMA press office today:

Jalopnik nails it on embargoes: Not agreeing to them means a huge advantage

Last week, Matt Hardigree, the editor-in-chief of Gawker Media-owned car site Jalopnik, riffed on embargoes following the leak of photos of the 2015 Ford Mustang.

The background discussion will be familiar to Embargo Watch readers: